Julius Knowles insider trades: Keros Therapeutics (KROS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Julius reports to the SEC
Open-market buys and sales
19 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | KROS | ↓ Sell | 2,625 | $10.73 | $28K | Direct | Jun 8, 2026 (4d) |
| Jan 5, 2022 | KROS | ↓ Sell | 47,651 | $57.84 | $2.8M | Indirect | Jan 5, 2022 (0d) |
| Dec 2, 2021 | KROS | ↓ Sell | 47,651 | $54.09 | $2.6M | Indirect | Dec 3, 2021 (1d) |
| Nov 3, 2021 | KROS | ↓ Sell | 47,651 | $42.12 | $2.0M | Indirect | Nov 3, 2021 (0d) |
| Oct 20, 2021 | KROS | ↓ Sell | 8,598 | $38.20 | $328K | Indirect | Oct 21, 2021 (1d) |
| Oct 18, 2021 | KROS | ↓ Sell | 26,367 | $38.56 | $1.0M | Indirect | Oct 18, 2021 (0d) |
| Oct 5, 2021 | KROS | ↓ Sell | 12,686 | $40.10 | $509K | Indirect | Oct 5, 2021 (0d) |
| Sep 27, 2021 | KROS | ↓ Sell | 95,302 | $41.17 | $3.9M | Indirect | Sep 29, 2021 (2d) |
| Jul 2, 2021 | KROS | ↓ Sell | 47,652 | $41.31 | $2.0M | Indirect | Jul 6, 2021 (4d) |
| Jun 7, 2021 | KROS | ↓ Sell | 19,415 | $49.07 | $953K | Indirect | Jun 8, 2021 (1d) |
| Jun 3, 2021 | KROS | ↓ Sell | 28,236 | $49.71 | $1.4M | Indirect | Jun 3, 2021 (0d) |
| May 4, 2021 | KROS | ↓ Sell | 47,651 | $57.27 | $2.7M | Indirect | May 5, 2021 (1d) |
| Apr 6, 2021 | KROS | ↓ Sell | 9,298 | $58.81 | $547K | Indirect | Apr 8, 2021 (2d) |
| Apr 5, 2021 | KROS | ↓ Sell | 38,353 | $59.72 | $2.3M | Indirect | Apr 5, 2021 (0d) |
| Mar 4, 2021 | KROS | ↓ Sell | 23,959 | $56.45 | $1.4M | Indirect | Mar 5, 2021 (1d) |
| Mar 2, 2021 | KROS | ↓ Sell | 23,690 | $61.13 | $1.4M | Indirect | Mar 3, 2021 (1d) |
| Feb 18, 2021 | KROS | ↓ Sell | 28,617 | $60.87 | $1.7M | Indirect | Feb 18, 2021 (0d) |
| Feb 12, 2021 | KROS | ↓ Sell | 19,029 | $63.53 | $1.2M | Indirect | Feb 16, 2021 (4d) |
| Apr 13, 2020 | KROS | ↑ Buy | 1,191 | $20.98 | $25K | Direct | Jan 20, 2023 (1012d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KROS insiders
Open-market trades in the last 12 months
About Julius Knowles's insider trades
Julius Knowles is an insider at Keros Therapeutics (KROS). Since Apr 13, 2020, Julius has reported 1 open-market purchase worth $25K and 18 sales worth $28.8M on SEC Form 4. In the last 12 months: 1 sale ($28K).
Their filings also include grants and awards (5 filings), shares returned to the company (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KROS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.